n. ************；叔丁啡
Objective: To study the efficacy of buprenorphine on opioids dependence treatment.
目的：探讨************對阿片類藥物依賴的治療作用。
Objective To evaluate the analgesic efficacy and safety of PCA with buprenorphine after abdominal cancer surgery.
目的評價************在腹部腫瘤手術後患者自控鎮痛（PCA）的效果和安全性。
Objective To observe the efficacy of buprenorphine used for postoperative epidural analgesia in patients with severe preeclampsia.
目的觀察************用于子痫前期患者剖宮産術後硬膜外鎮痛的效果及副作用。
Conclusions:Medium pain could be relieved by buprenorphine sublingual tablet with less ADRs incidence rate and no intolerance and dependence were observed.
結論：舌下含片************可有效緩解中度以上疼痛，不良反應發生率較低，且無藥物耐受及身體依賴現象。
CONCLUSION:Buprenorphine combined with Chinese angelica parenteral solution and metoclopramide has synergistic effect on analgesia, and is easy to manipulate.
結論：************複合當歸和胃複安對鎮痛具有協同增效的作用，且簡單易行。
Objective:To assess the analgesic effects and side effects of buprenorphine sublingual tablet in dental treatment.
目的：臨床評價************舌下含片輔助齒科治療時的鎮痛效果及不良反應。
Objectives:To evaluate the safety of buprenorphine sublingual tablet in treatment of pains.
目的：考察國産************舌下含片用于治療疼痛的安全性。
Medicinal treatment includes drugs such as naltrexone, methadone and buprenorphine.
藥物治療方法中的藥物有納曲酮、*********和丁丙諾啡。
AIM:To evaluate the analgesic effect of initial dose of buprenorphine sublingual tablet in the clinical treatment of cancer pains and the adverse drug reactions(ADRs).
目的：臨床評價初始劑量的************含片對癌痛的鎮痛效果及藥物的不良反應。
None of the buprenorphine patients were deemed to have failed their treatment, as opposed to about 31 percent of those not getting the medication.
沒有************治療的患者被視為“治療失敗”，相對應的是，空白對照組有31%。
Conclusion Buprenorphine can be safely applied to skin-analgesia after thoracotomy.
結論************能夠安全有效地應用于開胸術後自控皮下鎮痛。
Buprenorphine, a synthetic derivative of Thebaine, is a strong new analgesic agent.
************是一種新型的阿片生物堿蒂巴因的衍生物。
None of the patients received buprenorphine by the standard oral delivery route.
沒有患者接受标準口服************的治療方法。
In developing countries, only 2% of these users receive treatment with methadone or buprenorphine for opioid dependence.6
在發展中國家，這些人中僅有2%獲得使用*********或丁丙諾啡針對阿片類藥物依賴進行的治療[6]。
RESULTS: The middle pain relief efficacy of scorpion venom group was 53 % and that of buprenorphine group was 47 %( P \u003e0.05).
結果：蠍毒組與************組中度疼痛緩解率分别為53%和4 7% （P \u003e0.0 5）。
Also, about two-thirds of those on an implantable buprenorphine regimen stuck to their treatment program for the full six months, while only about 31 percent of those getting no medication did so.
并且，三分之二的接受植入************的患者堅持他們的治療進行了完整的6個月，而空白對照的隻有31%。
Buprenorphine : This is a relatively new and important treatment medication.
目的：探讨************對阿片類藥物依賴的治療作用。
Objective To develope an easy to use, rapid and accurate test for detecting buprenorphine based on the principle of competitive immunoassay.
目的采用免疫競争法原理，建立一種簡便快速檢測************的方法。
Objective:To understand clinical application and research situation of buprenorphine in China mainland.
結論：************在我國大陸地區的臨床應用與研究正逐步加強。
Four buprenorphine delivery devices were implanted under the skin of one arm in 108 patients. Each device was set to slowly release 80 milligrams of medication.
其中108名患者在一個手臂下被植入4個************釋放裝置，每個裝置都可以緩慢釋放80mg的************。
Buprenorphine（丁丙諾啡）是一種重要的處方藥物，屬于阿片類藥物類别，但具有獨特的藥理學特性。它在臨床上主要用于兩個核心領域：
阿片類藥物使用障礙的治療
中重度疼痛的管理
關鍵藥理學特性：
重要安全警示： Buprenorphine 必須在醫生嚴格監督下使用。它可能導緻依賴、濫用風險（盡管低于海洛因等）、呼吸抑制（尤其與其它鎮靜劑聯用時）、低血壓等。突然停藥可能導緻戒斷症狀。孕婦使用需權衡利弊。
來源參考： 關于 Buprenorphine 的詳細藥理學、適應症、用法用量、安全信息等權威信息，請查閱：
丁丙諾啡（Buprenorphine）是一種人工合成的阿片類藥物，具有以下核心特性：
如需更完整的化學注冊或藥品審批信息，可參考FDA及歐洲藥典相關數據庫。
【别人正在浏覽】